SecBot SecBot
10-Q/A ·Filed Jul 21, 2026
NH

NHIV

NewHold Investment Corp IV
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago SEC0001213900-26-080091
Amended quarterly report (potential restatement)
Actionable Insight • Neutral

This is a purely administrative filing with no new information. The key event for NHIV is the April 2026 IPO, which provides a $201.25 million trust for a future business combination. Monitor for any announcement of a target or a business combination agreement.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
NHIV ▼ -0.35% at T+60d
NEUTRAL call -0.35% · α vs SPY -3.61% · entry $10.09 → $10.05
Entry = T+0 close
Jul 21, 2026
via day close
T+1d
+0.05%
call +0.05% · α +1.28%
$10.09
settled 3mo ago
T+5d
+0.15%
call +0.15% · α +2.55%
$10.10
settled 3mo ago
T+20d
+0.28%
call +0.28% · α -2.62%
$10.11
settled 2mo ago
T+60d
-0.35%
call -0.35% · α -3.61%
$10.05
settled 13d ago

Price Chart

Loading chart...

Executive Summary

NewHold Investment Corp IV filed Amendment No. 1 to its Form 10-Q for the quarter ended March 31, 2026, solely to correct typographical errors in the original filing. The amendment explicitly states it makes no material changes to the financial statements or other disclosures. The company is a pre-revenue blank-check SPAC that completed its IPO on April 16, 2026, raising $201.25 million in gross proceeds, which are held in trust pending a business combination.

Key Facts

  • Amendment is solely to correct typographical errors; no material changes to financials.
  • Company completed its IPO on April 16, 2026, raising $201,250,000 in gross proceeds.
  • As of March 31, 2026, the company had no cash, total assets of $281,000, and a shareholders' deficit of $60,000.
  • Net loss for Q1 2026 was $38,000.
  • The company has not yet selected a business combination target.

Financial Impact

No material financial impact from the amendment. The company's pre-IPO financials show a net loss of $38,000 and total assets of $281,000 as of March 31, 2026.

Risk Factors

  • No identified business combination target; risk of liquidation if no deal is completed within 24 months of IPO.
  • Pre-revenue SPAC with no operating history; value depends entirely on future acquisition.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
10-Q/A Filing (Primary)0001213900-26-080091
Document: ea029877001ex31-1.htm0001213900-26-080091
Document: ea029877001ex31-2.htm0001213900-26-080091
Document: ea029877001ex32-2.htm0001213900-26-080091
Document: ea029877001ex32-1.htm0001213900-26-080091
Document: 0001213900-26-080091-index-headers.html0001213900-26-080091
Document: 0001213900-26-080091-index.html0001213900-26-080091
Document: 0001213900-26-080091.txt0001213900-26-080091
2 reports for NHIV
Performance horizon
Filters
Rows
Reports for NHIV — sortable, filterable
TypeNow
Sep 28, 2026
29d ago
SC 13G
NEUTRAL ★ 3/10
$10.05 $10.05· 0.00%▲ +0.03%$10.05 (+0.00%)
Jul 21, 2026
13w ago
10-Q/A
NEUTRAL ★ 2/10
$10.09 $10.11▲ +0.28%▼ −2.62%$10.05 (−0.35%)
Showing 2 of 2

US Market Status

Market Open — Closes in 3h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 21, 2026